AMCP 2023, taking place March 21-24 in San Antonio, Texas, will feature 6 educational tracks, 3 keynote addresses, and an estimated 4000 managed care professionals in attendance.
Kicking off the afternoon of March 21 and concluding March 24, AMCP 2023, from the Academy of Managed Care Pharmacy, will take place in San Antonio, Texas.
There will be 6 educational tracks to choose from: Biosimilars; Drugs, Diseases, and the Managed Care Impact; Legislative and Regulatory Trends; Focus on Managed Care Pharmacy; Managed Care Research in Action; and Making the Way for Innovation.
Preconference activity will see a 90-minute panel discussion exploring incorporating value-based frameworks in the managed care arena and how these can be used to help facilitate coverage decisions on various pharmaceuticals and health technologies. It will be led by Kimberly Westrich, MA, director of value and access strategy at AmerisourceBergen. Additional topics to be covered include the importance of certain data points—chief among them, comparative clinical effectiveness and outcomes data—and the Inflation Reduction Act.
“It really has a full range of information. We’re going to be getting into a little bit of research, a little bit of real-world application, and even some policy prognostication,” Westrich said. “In the research perspective, we collaborated with the National Pharmaceutical Council to explore how payers are using value assessment information in their decision-making, and then we’ll have some information on how payers are using this in the real world.”
Day 1 is packed with sessions that cover how to navigate the regulatory landscape of biosimilar use and examine the impact of interchangeability status, both with potential to affect patient care; how prior authorization ties into clinical trial participation and data for these decisions can inform patient-focused care approaches; addressing health disparities; and improving patient outcomes in several disease states, including β-thalassemia, HIV, and cancer. The morning will also see a welcome breakfast for first-time meeting attendees and new AMCP members.
On day 2, the morning will feature engaging discussions on pharmaceutical marketplace trends, the drug pipeline, and legislative and regulatory updates, and the afternoon will encompass sessions on biosimilars, a spotlight on advances on hemophilia treatment, and aligning payers and manufacturers to succeed under value-based contracts. Late-afternoon sessions cover alternative payment models and racial health disparities in medication adherence.
The final day of AMCP 2023 will be a short one, concluding around lunch time. But before then, the morning will encompass satellite symposia on patient outcomes in acute myeloid leukemia and opioid analgesic therapy for chronic pain, as well as an in-depth education session on the Inflation Reduction Act.
This year's Science and Innovation Theaters will feature presentations on Rett syndrome, a rare neurodevelopmental disorder; zuranolone, which is being investigated for use in major depressive disorder and postpartum depression (and so far is not approved by the FDA); and the use of molecular diagnostics in oncology.
In addition to the overall 34 education sessions, 14 satellite symposia, and expo with 75-plus exhibitors, there will be 3 notable keynotes:
Bringing Connectivity to the Specialty Pharmacy Workflow
May 2nd 2024In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized the need to simplify the prescribing workflow for specialty medication through proactive messaging, automation, and interoperability.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More